Kim MO - Search Results

1

Semiparametric Approach to a Random Effects Quantile Regression Model.

Kim MO, Yang Y. Kim MO, et al. J Am Stat Assoc. 2011 Dec 1;106(496):1405-1417. doi: 10.1198/jasa.2011.tm10470.. J Am Stat Assoc. 2011. PMID: 22347760 Free PMC article.

2

Censored quantile regression for residual lifetimes.

Kim MO, Zhou M, Jeong JH. Kim MO, et al. Lifetime Data Anal. 2012 Apr;18(2):177-94. doi: 10.1007/s10985-011-9212-2. Epub 2011 Dec 20. Lifetime Data Anal. 2012. PMID: 22183141

3

Efficient quantile marginal regression for longitudinal data with dropouts.

Cho H, Hong HG, Kim MO. Cho H, et al. Among authors: kim mo. Biostatistics. 2016 Jul;17(3):561-75. doi: 10.1093/biostatistics/kxw007. Epub 2016 Mar 7. Biostatistics. 2016. PMID: 26951723

4

Practice of causal inference with the propensity of being zero or one: assessing the effect of arbitrary cutoffs of propensity scores.

Kang J, Chan W, Kim MO, Steiner PM. Kang J, et al. Among authors: kim mo. Commun Stat Appl Methods. 2016 Jan;23(1):1-20. doi: 10.5351/CSAM.2016.23.1.001. Epub 2016 Jan 31. Commun Stat Appl Methods. 2016. PMID: 31467864 Free PMC article.

5

Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.

Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, Mays M, Lopez CM, Kim MO, Franz DN. Krueger DA, et al. Among authors: kim mo. Ann Neurol. 2013 Nov;74(5):679-87. doi: 10.1002/ana.23960. Epub 2013 Sep 10. Ann Neurol. 2013. PMID: 23798472 Clinical Trial.

6

Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.

Jackson M, Ahmari N, Wu J, Rizvi TA, Fugate E, Kim MO, Dombi E, Arnhof H, Boehmelt G, Düchs MJ, Long CJ, Maier U, Trapani F, Hofmann MH, Ratner N. Jackson M, et al. Among authors: kim mo. J Pharmacol Exp Ther. 2023 May;385(2):106-116. doi: 10.1124/jpet.122.001431. Epub 2023 Feb 27. J Pharmacol Exp Ther. 2023. PMID: 36849412 Free PMC article.

7

C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.

Perrino MR, Ahmari N, Hall A, Jackson M, Na Y, Pundavela J, Szabo S, Woodruff TM, Dombi E, Kim MO, Köhl J, Wu J, Ratner N. Perrino MR, et al. Among authors: kim mo. Life Sci Alliance. 2024 Mar 8;7(5):e202302229. doi: 10.26508/lsa.202302229. Print 2024 May. Life Sci Alliance. 2024. PMID: 38458648 Free PMC article.

8

Evolving Therapeutic Strategies in Esophageal Squamous Cell Carcinoma: Advances and Perspectives.

Liu Z, Kim MO. Liu Z, et al. Among authors: kim mo. J Cancer Prev. 2024 Dec 30;29(4):99-104. doi: 10.15430/JCP.24.026. J Cancer Prev. 2024. PMID: 39790226 Free PMC article. Review.

9

Advances in Preventive and Therapeutic Strategies for Oral Cancer: A Short Review.

Ma L, Kim MO. Ma L, et al. Among authors: kim mo. J Cancer Prev. 2024 Dec 30;29(4):113-119. doi: 10.15430/JCP.24.027. J Cancer Prev. 2024. PMID: 39790224 Free PMC article. Review.

10

Mesenchymal Stem Cells Mediated Suppression of GREM2 Inhibits Renal Epithelial-Mesenchymal Transition and Attenuates the Progression of Diabetic Kidney Disease.

Ko MS, Yun JY, Kim S, Kim MO, Go SH, Jin HJ, Koh EH. Ko MS, et al. Among authors: kim mo. Int J Stem Cells. 2025 Jan 6. doi: 10.15283/ijsc24113. Online ahead of print. Int J Stem Cells. 2025. PMID: 39757007 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

729 results

Search Page

Filters